The invention relates to devices for inhalation therapy having an aerosol generator, in particular with an oscillatable membrane for nebulising a liquid or powder.
Devices for inhalation therapy having a controllable aerosol generator need to signal different operating states of the device to the patient. Indicator elements such as light emitting diodes or sound signal generators have been used to date for this purpose, by means of which the beginning and end of a therapy session, for example, or other information is indicated to the patient.
The invention shows a way in which acoustic signals can be emitted in a device for inhalation therapy without additional sound signal generators, for example to indicate specific operating states of the device to the patient.
This is achieved according to the invention by means of a device for inhalation therapy comprising an oscillatable membrane for nebulisiug a liquid, an oscillation generating device which has at least one connecting means for receiving an oscillation control signal and by means of which the membrane is caused to oscillate when the oscillation control signal is supplied such that a liquid disposed on one side of the membrane is nebulised through the membrane and is present on the other side of the membrane as an aerosol, and comprising a control means from which an oscillation control signal can be supplied to the at least one connecting means of the oscillation generating device such that the oscillation generating device causes the membrane to oscillate, with the control means being designed such that a further control signal of the control means can be supplied to the oscillation generating device, said further signal causing the membrane to oscillate in the audible frequency range so as to emit an audible signal for a user.
The invention is based on the in fact surprising realisation that in membrane nebulisers, the electromechanical transducer unit used to cause oscillation, generally a piezoelectric component, can also be caused to oscillate in the audible frequency range and the nebuliser membrane then functions as an electroacoustic transducer (signal generator) without nebulisation being impaired. It is also surprising that sufficiently high signal levels can be achieved, specifically also during the nebulising operation.
The solution according to the invention is basically suitable for all devices for inhalation therapy in which a controlled aerosol generator is used that is able to emit an audible sound signal when a corresponding control signal is supplied. The applicability of the invention is thus not restricted to membrane nebulisers, even though nebulisers of this type are especially advantageous.
The invention can thus be characterised, even in abstract, as a device for inhalation therapy comprising an aerosol generating device for nebulising a liquid or powder tat has a connecting means for receiving a control signal, and comprising a control means from which a first control signal can be supplied to the connecting means of the aerosol generating device such that the aerosol generating device nebulises the liquid, in which the control means is designed such that a second control signal of the control means can be supplied to the aerosol generating device, said second signal causing an. audible signal for a user to be emitted.
The invention is explained in more detail below by means of an embodiment and referring to the figure showing a schematic representation of a device for inhalation therapy according to the invention.
Shown in
A patient can inhale the aerosol provided in the nebulisation cavity 4 at the mouthpiece 11 of the nebuliser. So that there is a sufficient supply of air, one or more air holes 12 are provided in the housing of the nebuliser, through which ambient air can enter into the cavity 4 during inhalation and out of which the air inhaled by the patient can exit from the cavity 4 during exhalation.
In order to indicate to the patient that the device for inhalation therapy is in a specific operating state, a further control signal is supplied according to the invention to the oscillatable structure 1, 6, 7. The further control signal causes the membrane 1 to oscillate at an audible frequency such that the membrane 1 emits a sound signal which is audible for the patient. The emission of the sound signal can occur during the nebulisation operation of the membrane 1 without the two oscillations disturbing each other. This is surprising not only since in order to emit an audible sound a frequency in the audible range has to be selected, but also because sufficient energy also has to be supplied to the oscillatable structure 1, 6, 7 so that sound energy can be emitted to a perceptible extent. Nebulisation of the liquid and the quality of the aerosol generated are nevertheless not negatively influenced, particularly since the emission of the sound signal is generally restricted to comparatively short periods.
Therefore, a short sound signal of 0.5 to 2 seconds in length, for example, can be emitted if, following switching on, the optimal operating frequency of the oscillatable structure 1, 6, 7 was found by a search circuit and the membrane is in a steady state. The sound signal can then indicate to the patient that the device for inhalation therapy is ready for operation and that the therapy session can begin. After a specific period or following nebulisation of a predetermined amount of liquid, the end of the therapy session can likewise be signalled by means of a preferably different sounding sound signal. The sound signals are not restricted to mere notes, rather sound sequences or recorded or synthesised voice signals can also be used.
A generator circuit 13 is preferably provided to generate the further control signal, from which the further control signal is supplied to the oscillatable structure 1, 6, 7. The two provided connecting lines 8 and 9 are used for this purpose in the embodiment described herein, via which the oscillation control signal is also supplied to the oscillatable structure 1, 6, 7. The generator unit 13 is advantageously integrated in the control means 10.
The embodiment described in more detail above shows how the generation according to the invention of an acoustic signal for the patient occurs in a device for inhalation therapy having a membrane nebuliser. The description of the embodiment, however, also makes it clear that the invention can be applied to all devices for inhalation therapy in which an aerosol generating device is supplied with a control signal in order to generate an aerosol, and in which an oscillatable structure is used which can cause oscillations in the audible range in addition to the oscillations necessary for nebulisation.
Devices for inhalation therapy in which an electromechanical transducer unit, preferably in the form of a piezoelectric element, is provided are particularly suitable for the use of the invention.
This application is a continuation of international application number PCT/EP2002/011706, filed 18 Oct. 2002.
Number | Name | Date | Kind |
---|---|---|---|
4091297 | Stephens | May 1978 | A |
4300131 | Mitsui et al. | Nov 1981 | A |
4414512 | Nelson | Nov 1983 | A |
4533082 | Maehara et al. | Aug 1985 | A |
4775808 | Trumpp | Oct 1988 | A |
4790479 | Matsumoto et al. | Dec 1988 | A |
4866301 | Smith | Sep 1989 | A |
5152456 | Ross et al. | Oct 1992 | A |
5159340 | Smith | Oct 1992 | A |
5261601 | Ross et al. | Nov 1993 | A |
5272394 | Kirk et al. | Dec 1993 | A |
5440244 | Richter et al. | Aug 1995 | A |
5487378 | Robertson et al. | Jan 1996 | A |
5512853 | Ueno et al. | Apr 1996 | A |
5933026 | Larsen et al. | Aug 1999 | A |
6152130 | Abrams et al. | Nov 2000 | A |
6242949 | Wilford | Jun 2001 | B1 |
6402046 | Loser | Jun 2002 | B1 |
Number | Date | Country |
---|---|---|
199 62 280 | Jul 2001 | DE |
0 051 343 | May 1982 | EP |
0 844 736 | Nov 1996 | EP |
1 092 446 | Apr 2001 | EP |
9828846 | Jul 1998 | WO |
Number | Date | Country | |
---|---|---|---|
20050056274 A1 | Mar 2005 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/EP02/011706 | Oct 2002 | US |
Child | 10810098 | US |